Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-31

Clinical Trial Update: Impact of Exenatide on Sleep in Type 2 Diabetes [NA]

View source ↗

Summary

A completed clinical trial examined the impact of exenatide on sleep in individuals with type 2 diabetes, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXENATIDE (EXENATIDE)

Snippet

Sponsor: University of Chicago | Conditions: Type 2 Diabetes, Sleep Disordered Breathing | NA | Status: COMPLETED | Results posted: 2018-07-31